Role of calcium in platelet activation: Novel insights and pharmacological implications

Medicinal Chemistry

Volumn 12, Issue 2, 2016, Pages 131-138

  Davlouros, Periklis ^a   Xanthopoulou, Ioanna ^a   Mparampoutis, Nikolaos ^a   Giannopoulos, Georgios ^b   Deftereos, Spyridon ^b   Alexopoulos, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activation; Calcium; Kinetics; Platelets

Indexed keywords

CALCIUM; FIBRINOLYTIC AGENT;

ANIMAL; BLOOD; HUMAN; METABOLISM; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; CALCIUM; FIBRINOLYTIC AGENTS; HUMANS; PLATELET ACTIVATION; THROMBOSIS;

EID: 84958522410     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340641202160208195923     Document Type: Article

References (63)

1. Li, Z.; Delaney, M. K.; O'Brien, K. A.; Du, X. Signaling during platelet adhesion and activation. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 2341-2349.
2. Leslie, M. Cell biology. Beyond clotting: the powers of platelets. Science, 2010, 328, 562-564.
3. Jennings, L. K. Role of platelets in atherothrombosis. Am. J. Cardiol., 2009, 103, 4A-10A.
4. Kaplan, Z. S.; Jackson, S. P. The role of platelets in atherothrombosis. Hematol. Am. Soc. Hematol. Educ. Program, 2011, 2011, 51-61.
5. Stone, G. W.; Witzenbichler, B.; Guagliumi, G.; Peruga, J. Z.; Brodie, B. R.; Dudek, D.; Kornowski, R.; Hartmann, F.; Gersh, B. J.; Pocock, S. J.; Dangas, G.; Wong, S. C.; Fahy, M.; Parise, H.; Mehran, R.; Investigators, H.-A. T. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxeleluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet, 2011, 377, 2193-2204.
6. Linden, M. D.; Jackson, D. E. Platelets: pleiotropic roles in atherogenesis and atherothrombosis. Int. J. Biochem. Cell. Biol., 2010, 42, 1762-1766.
7. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet, 1988, 2, 349-3460.
8. Yusuf, S.; Zhao, F.; Mehta, S. R.; Chrolavicius, S.; Tognoni, G.; Fox, K. K.; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial, I. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N. Engl. J. Med., 2001, 345, 494-502.
9. Wiviott, S. D.; Braunwald, E.; McCabe, C. H.; Montalescot, G.; Ruzyllo, W.; Gottlieb, S.; Neumann, F. J.; Ardissino, D.; De Servi, S.; Murphy, S. A.; Riesmeyer, J.; Weerakkody, G.; Gibson, C. M.; Antman, E. M.; Investigators, T.-T. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med., 2007, 357, 2001-2015.
10. Wallentin, L.; Becker, R. C.; Budaj, A.; Cannon, C. P.; Emanuelsson, H.; Held, C.; Horrow, J.; Husted, S.; James, S.; Katus, H.; Mahaffey, K. W.; Scirica, B. M.; Skene, A.; Steg, P. G.; Storey, R. F.; Harrington, R. A.; Investigators, P.; Freij, A.; Thorsen, M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl. J. Med., 2009, 361, 1045-1057.
11. El Mallah, W.; Moliterno, D. J. Early and late outcome associated with bleeding events in the setting of dual antiplatelet therapy following stent placement. Catheter. Cardiovasc. Interv., 2012, 80, 406-407.
12. Xanthopoulou, I.; Deftereos, S.; Sitafidis, G.; Kanakakis, I.; Hamilos, M.; Karayannis, G.; Angelidis, C.; Stavrou, K.; Vavuranakis, M.; Goudevenos, J. A.; Stefanadis, C.; Alexopoulos, D. In-hospital bleeding events in acute coronary syndrome patients undergoing percutaneous coronary intervention in the era of novel P2Y12 inhibitors: insights from the GReek AntiPlatelet rEgistry-GRAPE. Int. J. Cardiol., 2014, 174, 160-162.
13. Campo, G.; Fileti, L.; de Cesare, N.; Meliga, E.; Furgieri, A.; Russo, F.; Colangelo, S.; Brugaletta, S.; Ferrari, R.; Valgimigli, M.; Investigators, T. R. Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel) trial substudy. J. Am. Coll. Cardiol., 2010, 56, 1447-1455.
14. Pamukcu, B.; Oflaz, H.; Oncul, A.; Umman, B.; Mercanoglu, F.; Ozcan, M.; Meric, M.; Nisanci, Y. The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events. J. Thromb. Thrombolysis., 2006, 22, 103-110.
15. Alexopoulos, D.; Galati, A.; Xanthopoulou, I.; Mavronasiou, E.; Kassimis, G.; Theodoropoulos, K. C.; Makris, G.; Damelou, A.; Tsigkas, G.; Hahalis, G.; Davlouros, P. Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study. J. Am. Coll. Cardiol., 2012, 60, 193-199.
16. Alexopoulos, D.; Xanthopoulou, I.; Gkizas, V.; Kassimis, G.; Theodoropoulos, K. C.; Makris, G.; Koutsogiannis, N.; Damelou, A.; Tsigkas, G.; Davlouros, P.; Hahalis, G. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction. Circ. Cardiovasc. Interv. 2012, 5, 797-804.
17. Alexopoulos, D.; Xanthopoulou, I.; Deftereos, S.; Sitafidis, G.; Kanakakis, I.; Hamilos, M.; Vavuranakis, M.; Davlouros, P.; Ntalas, I.; Angelidis, C.; Hahalis, G.; Triposkiadis, F.; Vardas, P.; Stefanadis, C.; Goudevenos, J. A.; Investigators, G. Contraindications/ special warnings and precautions for use of contemporary oral antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Circ. J., 2014, 78, 180-187.
18. Savage, B.; Almus-Jacobs, F.; Ruggeri, Z. M. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell, 1998, 94, 657-666.
19. De Meyer, S. F.; Stoll, G.; Wagner, D. D.; Kleinschnitz, C. von Willebrand factor: an emerging target in stroke therapy. Stroke, 2012, 43, 599-606.
20. Broos, K.; De Meyer, S. F.; Feys, H. B.; Vanhoorelbeke, K.; Deckmyn, H. Blood platelet biochemistry. Thromb. Res., 2012, 129, 245-249.
21. Varga-Szabo, D.; Braun, A.; Nieswandt, B. Calcium signaling in platelets. J. Thromb. Haemost., 2009, 7, 1057-1066.
22. FitzGerald, G. A. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am. J. Cardiol., 1991, 68, 11B-15B.
23. Rink, T. J.; Sage, S. O. Calcium signaling in human platelets. Annu. Rev. Physiol., 1990, 52, 431-49.
24. Stefanini, L.; Roden, R. C.; Bergmeier, W. CalDAG-GEFI is at the nexus of calcium-dependent platelet activation. Blood, 2009, 114, 2506-2514.
25. Bird, G. S.; Aziz, O.; Lievremont, J. P.; Wedel, B. J.; Trebak, M.; Vazquez, G.; Putney, J. W., Jr. Mechanisms of phospholipase Cregulated calcium entry. Curr. Mol. Med., 2004, 4, 291-301.
26. Rosado, J. A.; Jenner, S.; Sage, S. O. A role for the actin cytoskeleton in the initiation and maintenance of store-mediated calcium entry in human platelets. Evidence for conformational coupling. J. Biol. Chem., 2000, 275, 7527-7533.
27. Bakowski, D.; Parekh, A. B. Regulation of store-operated calcium channels by the intermediary metabolite pyruvic acid. Curr. Biol. 2007, 17, 1076-1081.
28. Vig, M.; Peinelt, C.; Beck, A.; Koomoa, D. L.; Rabah, D.; Koblan-Huberson, M.; Kraft, S.; Turner, H.; Fleig, A.; Penner, R.; Kinet, J. P. CRACM1 is a plasma membrane protein essential for storeoperated Ca2+ entry. Science, 2006, 312, 1220-1223.
29. Braun, A.; Varga-Szabo, D.; Kleinschnitz, C.; Pleines, I.; Bender, M.; Austinat, M.; Bosl, M.; Stoll, G.; Nieswandt, B. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood, 2009, 113, 2056-2063.
30. Bergmeier, W.; Stefanini, L. Novel molecules in calcium signaling in platelets. J. Thromb. Haemost., 2009, 7(Suppl 1), 187-190.
31. Stathopulos, P. B.; Zheng, L.; Li, G. Y.; Plevin, M. J.; Ikura, M. Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell, 2008, 135, 110-122.
32. Varga-Szabo, D.; Braun, A.; Kleinschnitz, C.; Bender, M.; Pleines, I.; Pham, M.; Renne, T.; Stoll, G.; Nieswandt, B. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J. Exp. Med., 2008, 205, 1583-1591.
33. Hassock, S. R.; Zhu, M. X.; Trost, C.; Flockerzi, V.; Authi, K. S. Expression and role of TRPC proteins in human platelets: evidence that TRPC6 forms the store-independent calcium entry channel. Blood, 2002, 100, 2801-2811.
34. Authi, K. S. TRP channels in platelet function. Handb. Exp. Pharmacol., 2007, ((179), 425-443.
35. Rosado, J. A.; Sage, S. O. Coupling between inositol 1,4,5-trisphosphate receptors and human transient receptor potential channel 1 when intracellular Ca2+ stores are depleted. Biochem. J., 2000, 350(Pt 3), 631-635.
36. Varga-Szabo, D.; Authi, K. S.; Braun, A.; Bender, M.; Ambily, A.; Hassock, S. R.; Gudermann, T.; Dietrich, A.; Nieswandt, B. Storeoperated Ca(2+) entry in platelets occurs independently of transient receptor potential (TRP) C1. Pflugers. Arch., 2008, 457, 377-387.
37. Vial, C.; Hechler, B.; Leon, C.; Cazenave, J. P.; Gachet, C. Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines. Thromb. Haemost., 1997, 78, 1500-1504.
38. Mahaut-Smith, M. P.; Ennion, S. J.; Rolf, M. G.; Evans, R. J. ADP is not an agonist at P2X(1) receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Br. J. Pharmacol., 2000, 131, 108-114.
39. Jones, S.; Evans, R. J.; Mahaut-Smith, M. P. Ca2+ influx through P2X1 receptors amplifies P2Y1 receptor-evoked Ca2+ signaling and ADP-evoked platelet aggregation. Mol. Pharmacol., 2014, 86, 243-251.
40. Enyedi, A.; Sarkadi, B.; Foldes-Papp, Z.; Monostory, S.; Gardos, G. Demonstration of two distinct calcium pumps in human platelet membrane vesicles. J. Biol. Chem., 1986, 261, 9558-9563.
41. Papp, B.; Enyedi, A.; Kovacs, T.; Sarkadi, B.; Wuytack, F.; Thastrup, O.; Gardos, G.; Bredoux, R.; Levy-Toledano, S.; Enouf, J. Demonstration of two forms of calcium pumps by thapsigargin inhibition and radioimmunoblotting in platelet membrane vesicles. J. Biol. Chem., 1991, 266, 14593-14596.
42. Enouf, J.; Bredoux, R.; Papp, B.; Djaffar, I.; Lompre, A. M.; Kieffer, N.; Gayet, O.; Clemetson, K.; Wuytack, F.; Rosa, J. P. Human platelets express the SERCA2-b isoform of Ca(2+)-transport ATPase. Biochem. J., 1992, 286( Pt 1), 135-140.
43. Rosado, J. A. Acidic Ca(2+) stores in platelets. Cell. Calcium, 2011, 50, 168-174.
44. Jardin, I.; Ben Amor, N.; Bartegi, A.; Pariente, J. A.; Salido, G. M.; Rosado, J. A. Differential involvement of thrombin receptors in Ca2+ release from two different intracellular stores in human platelets. Biochem. J., 2007, 401, 167-174.
45. Rosado, J. A.; Lopez, J. J.; Harper, A. G.; Harper, M. T.; Redondo, P. C.; Pariente, J. A.; Sage, S. O.; Salido, G. M. Two pathways for store-mediated calcium entry differentially dependent on the actin cytoskeleton in human platelets. J. Biol. Chem., 2004, 279, 29231-29235.
46. Zbidi, H.; Jardin, I.; Woodard, G. E.; Lopez, J. J.; Berna-Erro, A.; Salido, G. M.; Rosado, J. A. STIM1 and STIM2 are located in the acidic Ca2+ stores and associates with Orai1 upon depletion of the acidic stores in human platelets. J. Biol. Chem.., 2011, 286, 12257-712260.
47. Mazepa, M.; Hoffman, M.; Monroe, D. Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets. Arterioscler. Thromb. Vasc. Biol., 2013, 33, 1747-1752.
48. Shi, J.; Pipe, S. W.; Rasmussen, J. T.; Heegaard, C. W.; Gilbert, G. E. Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure. J. Thromb. Haemost., 2008, 6, 1167-1174.
49. van der Meijden, P. E.; Feijge, M. A.; Giesen, P. L.; Huijberts, M.; van Raak, L. P.; Heemskerk, J. W. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thromb. Haemost., 2005, 93, 1128-1136.
50. Dale, G. L. Coated-platelets: an emerging component of the procoagulant response. J. Thromb. Haemost., 2005, 3, 2185-2192.
51. Fager, A. M.; Wood, J. P.; Bouchard, B. A.; Feng, P.; Tracy, P. B. Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 2400-247.
52. Gilio, K.; van Kruchten, R.; Braun, A.; Berna-Erro, A.; Feijge, M. A.; Stegner, D.; van der Meijden, P. E.; Kuijpers, M. J.; Varga-Szabo, D.; Heemskerk, J. W.; Nieswandt, B. Roles of platelet STIM1 and Orai1 in glycoprotein VI-and thrombin-dependent procoagulant activity and thrombus formation. J. Biol. Chem., 2010, 285, 23629-23638.
53. Remenyi, G.; Szasz, R.; Friese, P.; Dale, G. L. Role of mitochondrial permeability transition pore in coated-platelet formation. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 467-471.
54. Jobe, S. M.; Wilson, K. M.; Leo, L.; Raimondi, A.; Molkentin, J. D.; Lentz, S. R.; Di Paola, J. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood, 2008, 111, 1257-1265.
55. Authi, K. S. Orai1: a channel to safer antithrombotic therapy. Blood, 2009, 113, 1872-1873.
56. Muik, M.; Frischauf, I.; Derler, I.; Fahrner, M.; Bergsmann, J.; Eder, P.; Schindl, R.; Hesch, C.; Polzinger, B.; Fritsch, R.; Kahr, H.; Madl, J.; Gruber, H.; Groschner, K.; Romanin, C. Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J. Biol. Chem., 2008, 283, 8014-8022.
57. Bergmeier, W.; Oh-Hora, M.; McCarl, C. A.; Roden, R. C.; Bray, P. F.; Feske, S. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood, 2009, 113, 675-678.
58. van Kruchten, R.; Braun, A.; Feijge, M. A.; Kuijpers, M. J.; Rivera-Galdos, R.; Kraft, P.; Stoll, G.; Kleinschnitz, C.; Bevers, E. M.; Nieswandt, B.; Heemskerk, J. W. Antithrombotic potential of blockers of store-operated calcium channels in platelets. Arterioscler. Thromb. Vasc. Biol., 2012, 32, 1717-1723.
59. Le Deist, F.; Hivroz, C.; Partiseti, M.; Thomas, C.; Buc, H. A.; Oleastro, M.; Belohradsky, B.; Choquet, D.; Fischer, A. A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood, 1995, 85, 1053-1062.
60. Oury, C.; Kuijpers, M. J.; Toth-Zsamboki, E.; Bonnefoy, A.; Danloy, S.; Vreys, I.; Feijge, M. A.; De Vos, R.; Vermylen, J.; Heemskerk, J. W.; Hoylaerts, M. F. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood, 2003, 101, 3969-3976.
61. Stefanini, L.; Bergmeier, W. CalDAG-GEFI and platelet activation. Platelets, 2010, 21, 239-243.
62. Ahmad, F.; Boulaftali, Y.; Greene, T. K.; Ouellette, T. D.; Poncz, M.; Feske, S.; Bergmeier, W. Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis. J. Thromb. Haemost., 2011, 9, 2077-2086.
63. Schoenwaelder, S. M.; Jarman, K. E.; Gardiner, E. E.; Hua, M.; Qiao, J.; White, M. J.; Josefsson, E. C.; Alwis, I.; Ono, A.; Willcox, A.; Andrews, R. K.; Mason, K. D.; Salem, H. H.; Huang, D. C.; Kile, B. T.; Roberts, A. W.; Jackson, S. P. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood, 2011, 118, 1663-1674.